^
Association details:
| Biomarker: | KDR expression |
|---|---|
| Cancer: | Cervical Cancer |
| Drug: | Endostar (recombinant human endostatin) (VEGF inhibitor) |
| Direction: | Sensitive |
Evidence:
Source:
Title:
Endostar, an Anti-angiogenesis Inhibitor, Combined with Chemoradiotherapy for Locally Advanced Cervical Cancer
Published date:
09/20/2021
Excerpt:
Patients in the CCRT+E arm had significantly longer PFS, OS, and DMFS than those in the CCRT arm whenVEGFR2 expression was positive. In conclusion, CCRT plus Endostar significantly improved DMFS but not PFS over CCRT alone. The addition of Endostar could significantly improve survival for patients with positive VEGFR2 expression.
DOI:
10.3727/096504021X16318716607908
